Skip to main content
OpenTrials
Completed

NCT Number: NCT04577261

FNS (FEMORAL NECK SYSTEM) Study

A post-market, prospective study to evaluate the reoperation rate of displaced and nondisplaced femoral neck fractures treated with the Femoral Neck System (FNS)™

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Wake Forest Health Sciences

Winston-Salem, North Carolina, 27157, United States

About this study

To evaluate the re-operation rate for any reason of displaced and non-displaced femoral neck fractures treated with the Femoral Neck System (FNS)™ at one year post-operation. The Femoral Neck System (FNS)™ represents a new generation of implants designed to improve outcomes in the treatment of femoral neck fractures. These implants offer a fixed angle construct and all of its mechanical advantages with regards to neutralizing shear and providing stability while not exerting a rotational malreduction force on the fracture. The FNS system has been shown to compare favorably to traditional fixed angle constructs in a cadaveric model

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The subject must provide written informed consent
  • The subject must be eighteen (18) years of age or older.
  • The subject must be willing and able to make all required study visits including one (1) year post-operative follow-up.
  • The subject must be able to follow instructions.
  • Subject has experienced displaced or non-displaced intracapsular femoral neck fracture

Exclusion criteria

  • Subject with fracture occurring more than 7 days prior to the date of surgery
  • Subject has more than one fracture on target extremity.
  • Subject is obese as defined by a Body Mass Index (BMI) > 45 at the time of surgery.
  • Subject, in the opinion of the Investigator, has an emotional or neurological condition that preludes cooperation and compliance with the rehabilitation regimen.
  • Therapy with another investigational agent within thirty (30) days of Screening or planned therapy with another investigational agent during the course of the study.
  • Subject has a physical condition that, in the opinion of the Investigator, would preclude adequate implant support or impede healing (e.g. blood supply impairment insufficient bone quality or quantity, or an active, local or systemic infection). If this is identified at the time of surgery, the subject will be screen failed.
  • Subject has undergone previous surgery on the target hip.
  • Current systemic therapy with cytotoxic drugs.
  • Subjects with a history of poor compliance with medical treatment.
  • Subjects with a medical or physical condition that, in the opinion of the Investigator, would preclude safe subject participation in the study.

Treatment and study plan

Primary outcomes

  1. Re-operation rate

    Time frame: Year 1 post-operation

    Re-operation rate for any reason of displaced and non-displaced femoral neck fractures treated with the Femoral Neck System (FNS)™

Secondary outcomes

  1. Timed Up and Go (TUG) time

    Time frame: Week 6, Months 3, 6, and 12

    The Timed Up and Go Test assesses mobility, balance, walking ability, and fall risk in adults by measuring time, in seconds, that it takes the individual to stand from a chair, walk a distance of 10 feet, walk back to the chair, and sit down. The subject will perform the test in their everyday footwear with their walking aid (cane, walker), if applicable. Normal healthy elderly usually complete the task in ten seconds or less. Very frail or weak elderly with poor mobility may take 2 minutes or more. 8

  2. European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L) Score

    Time frame: Baseline, Week 6, Months 3, 6, and 12

    The EuroQol EQ-5D-5L is a standardized instrument for use as a measurement of health outcome. It consists of a descriptive system with 5 dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), which are each assigned five levels (no problems, slight problems, moderate problems, severe problems and extreme problems) The first part (descriptive system with 5 dimensions) is scored using the Health state index scores. Health state index scores generally range from less than 0 (where 0 is the value of a health state equivalent to dead; negative values representing values as worse than dead) to 1 (the value of full health), with higher scores indicating higher health utility.

  3. European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L) - VAS (Visual Analogue Scale) Score

    Time frame: Baseline, Week 6, Months 3, 6, and 12

    The EuroQol EQ-5D-5L is a standardized instrument for use as a measurement of health outcome. It consists of a descriptive system with 5 dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), which are each assigned five levels (no problems, slight problems, moderate problems, severe problems and extreme problems), as well as, a Visual Analogue Scale where subjects indicate a numerical value from 0-100 where 0 is the worst imaginable health state and 100 is the best imaginable health state.

  4. Visual Analogue Scale (VAS) for Pain Score

    Time frame: Baseline, Week 6, Months 3, 6, and 12

    The Visual Analogue Scale is simply a line of fixed length, on which the subject marks their experience of pain with a single stroke of a pen - The subject will record their level of pain on a 100 mm visual analog scale - the scale will be marked 'no pain' on the left side of the scale and 'severe pain' at the right end of the scale - It is generally accepted that a pain VAS score of 30, 70, and 100 indicates the upper boundaries of mild, moderate, and severe pain intensity

  5. Number of Participants with Quality of Fracture Reduction

    Time frame: Baseline, Week 6, Months 3, 6, and 12

    Appropriate reduction will be defined as the principal compressive trabeculae measuring >160° in the AP view and <5° of posterior angulation in the lateral view. If reduction is acceptable in both views, it will be classified as grade I. Grade II will be indicative of one plane of malreduction, and grade III will be indicative of malreduction in both radiographic views.

    Pre-operative radiographs will be reviewed and classified as displaced (e.g. Garden III & IV) or non-displaced (e.g. Garden I & II) femoral neck fractures by the Investigator at each site Pauwel Classification (Type I - 30 degrees, Type II - 50 degrees, Type III - 70 degrees)

  6. Active Straight Leg Raise (ASLR) Assessment Score

    Time frame: Baseline, Week 6, Months 3, 6, and 12

    The ALSR assessment provides information about the ability of load transfer and motor control strategies in the lumbo/pelvic/hip complex. ASLR will be performed with the subject in a relaxed supine position with legs straight and feet apart. Subjects will be instructed to raise their operated leg 20cm above the examination table without bending the knee and without pelvic movement relative to the trunk. A score will be provided by the subject for the operated limb on a six-point Likert scale (0 = not difficult at all, 1 = minimally difficult; 2 = somewhat able to do, 3 = fairly difficult, 4 = very difficult, 5 = unable to do) -Lower score denotes better outcome

  7. Number of Participants with Intraoperative complications

    Time frame: Baseline, Week 6, Months 3, 6, and 12

    Number of Participants with Intraoperative complications

  8. Radiographic outcomes including quality of fracture reduction

    Time frame: Baseline, Week 6, Months 3, 6, and 12

    Perform radiology imaging collecting both anteroposterior (AP) and lateral images of the target hip to ensure the FNS is properly implanted - (healed, non-union, aligned, mal-union, osteonecrosis of femoral head, no osteonecrosis of femoral head, none)

  9. Number of Construct failure past 6 months

    Time frame: Months 6 and 12

    Construct failure past typical femoral neck fracture healing period (past 6 months)

  10. Time to return to full weight-bearing

    Time frame: Week 6, Months 3, 6, and 12

    Time to return to full weight-bearing

  11. Ambulatory status from pre-injury to study completion

    Time frame: Baseline, Week 6, Months 3, 6, and 12

    Subjects will be assessed as "Unaided", "Using a cane", "Using a walker" or "Bed to Chair"

  12. Length of hospital stay

    Time frame: Week 6, Months 3, 6, and 12

    Length of hospital stay

  13. Number of Hospital readmission for any reason

    Time frame: Week 6, Months 3, 6, and 12

    Number of Hospital readmission for any reason

Sponsors and collaborators

Lead sponsor

Wake Forest University Health Sciences

Other

Registry information

Official study title

A Prospective Study To Evaluate The FEMORAL NECK SYSTEM (FNS) In The Treatment Of INTRA-CAPSULAR FEMORAL Neck Fractures

Acronym: FNS

Important dates

Study start
2020
Primary completion
2026
Study completion
2026
First posted
Oct 6, 2020
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.